Neglected Tropical Disease Treatment Market

Report Highlights

The report focused on the different diseases of neglected tropical disease and the type of drugs and vaccines used for treating the disease. The report also focuses on the initiatives takes by the government and non-government regulatory authorities. Furthermore, the scope of the report also covers the impact of COVID-19 and drivers and challenges for neglected tropical disease treatment market. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each by disease, product type, route of administration, end-user and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional neglected tropical disease treatment markets; it explains the major market drivers of the global neglected tropical disease treatment industry, current trends within the industry, major applications, and the regional dynamics of the global neglected tropical disease treatment market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global neglected tropical disease treatment market.

Report Includes

• 41 tables and 49 figures
• An up-to-date analysis of the Global Neglected Tropical Disease Treatment Market.
• Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
• Estimation of market size and revenue forecast for Global Neglected Tropical Disease Treatment Market, and corresponding market share analysis by disease, product type, route of administration, end-user, and region.
• Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Neglected Tropical Disease Treatment, identification of the companies that are best positioned to meet this demand.
• In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
• Identification of promising new vaccines, and drugs still in the development and testing stages, and their probability of successful commercial launch within the next five years
• Impact of COVID-19 on the Neglected Tropical Disease Treatment Market as compared to overall global economy.
• Insight into the growth development strategies of major Neglected Tropical Disease Treatment manufacturers and their key competitive landscape
• Descriptive company profiles of the leading market participants, including F. Hoffmann-La Roche AG, Sanofi S.A., Eisai Co. Ltd., Pfizer, Inc., Novartis International AG, GlaxoSmithKline plc, Bayer AG, Abbott Laboratories, and others.

Summary

Neglected tropical diseases (NTDs) are a varied group of infections found mostly in the tropical region such as, some of the regions of Africa, America, and even Asia’s. These diseases are mainly caused by different kinds of pathogens which include, bacteria, protozoa, viruses, many others. WHO stated that neglected tropical diseases affects approximately 1 billion people or even more in the poor population. It has been observed that the low or middle-income countries have higher prevalence of these diseases due to lack of proper health facilities.